Literature DB >> 9417179

[Maculo-ocular reflex and visual perception during vertical acceleration].

F Schmäl1, W Stoll.   

Abstract

BACKGROUND: We investigated the effect of vertical acceleration upon the otolithic-ocular reflex of 22 healthy people. The study was performed to obtain standard values for subsequent investigations at patients.
METHODS: People sitting on a chair were accelerated in the vertical axis with an amplitude of 4 cm and the frequencies of 0.5 Hz, 1 Hz, 1.5 Hz, 2 Hz, 2.5 Hz and 2.7 Hz. The movements of the ocular globe were initially recorded during vertical acceleration with the eyes closed. Then visual acuity was tested during linear acceleration with the eyes open. As parameters of evaluation we used coherence and alteration of the visual acuity.
RESULTS: When the frequency was increased while the eyes were closed, coherence increased and the number of people with vertical eye movements increased. Amplitude was observed to increase and a phase shift occurred. A significant value of coherence (> 0.8) was observed at a frequency above 2.5 Hz. During the test of visual acuity, coherence also increased but did not reach quantity we observed initially. A significant loss of visual acuity occurred at a frequency above 2.5 Hz. A phase shift was also observed. The reason for the loss of visual acuity was the increment of amplitude and the phase shift, which had a negative influence on fixation.
CONCLUSIONS: In summary, reactions with closed eyes are best tested at frequencies of 2.5 and 2.7 Hz. We recommended frequencies of 1.5 and 2 Hz for testing visual acuity.

Entities:  

Mesh:

Year:  1997        PMID: 9417179     DOI: 10.1055/s-2007-997472

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  1 in total

1.  [Vestibular evoked muscle potentials dependency on neural origin and the location of an acoustic neuroma].

Authors:  C Hamann; J Rudolf; H von Specht; B Freigang
Journal:  HNO       Date:  2005-08       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.